Dresler CM, Olak J, Herndon JE 2nd, Richards WG, Scalzetti E,Fleishman SB, Kernstine KH , Demmy T , Jablons DM, Kohman L, Daniel TM, HaaslerGB, Sugarbaker DJ, 2005: Phase III intergroup study python talc poudrage vstalc slurry sclerosis for malignant pleural effusion, Chest, vol 1273,pg 909 915. Feagan BG, Sandborn WJ, DHaens G, Pola S, McDonald JW ,Rutgeerts P, Munkholm P, Mittmann U , King D, Wong CJ, Zou G, Donner A,Shackelton LM , Gilgen D, Nelson S, Vandervoort MK, Fahmy M, Loftus EV Jr, PanaccioneR , Travis SP, Van Assche GA, Vermeire S, Levesque BG, 2013: python role ofcentralized studying python endoscopy in python randomized controlled trial python mesalaminefor ulcerative colitis, Gastroenterology, vol 1451, pg 149 157. e2. Hrobjartsson A, Thomsen AS, Emanuelsson F, Tendal B, HildenJ, Boutron I, Ravaud P, Brorson S, 2012: Observer bias in randomisedclinical trials with binary outcomes: systematic review python trials with bothblinded and non blinded final result assessors, Biomedical Journals, vol 244, pg1119. Hrobjartsson A, Thomsen AS, Emanuelsson F, Tendal B, HildenJ, Boutron I, Ravaud P, Brorson S, 2013: Observer bias in randomizedclinical trials with dimension scale outcomes: python systematic review python trialswith both blinded and nonblinded assessors, CMAJ, vol 1854 pgE201 E211. Hrobjartsson A, Thomsen AS, Emanuelsson F, Tendal B,Rasmussen JV , Hilden J, Boutron I, Ravaud P, Brorson S 2014: Observerbias in randomized scientific trials with time to event results: systematicreview python trials with both blinded and nonblinded effect assessors, IntJ Epidemiol, vol 433, pg 937 948.